P

Phio Pharmaceuticals Corp
D

PHIO

2.18000
USD
-0.20
(-8.40%)
مغلق
حجم التداول
1,570
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
12,484,315
أصول ذات صلة الأخبار المقالات

العنوان: Phio Pharmaceuticals Corp

القطاع: Healthcare
الصناعة: Biotechnology
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.